• Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Bulgaria Czechia France Germany Greece Hungary +4

  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Austria Finland France Germany Ireland Italy +6

  • Study on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1
    Investigated diseases:
    Austria Belgium Denmark Germany Italy Spain

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated diseases:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Denmark France Germany Italy Spain

  • Study on the Safety and Feasibility of Diamyd (Glutamate Decarboxylase 2) for Individuals Aged 8-17 at Risk for Type 1 Diabetes with HLA DR3-DQ2 Haplotype

    Not recruiting

    2 1 1
    Investigated diseases:
    Sweden

  • Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium France Germany Italy Poland Spain +1

  • Study on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Denmark France Germany Greece Hungary +5

  • Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1
    Investigated diseases:
    Spain

powered by